| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.007 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |